Biotechnology company Stem Cell Therapeutics Corp (CVE:SSS) reported Thursday that both the U.S. and Japan patent offices have granted the company patents for drugs used to treat stroke and multiple sclerosis.
Stroke
A stroke is an interruption of the blood supply to any part of the brain. A stroke is sometimes called a "brain attack."
multiple sclerosis
Multiple sclerosis is an autoimmune disease that affects the brain and spinal cord (central nervous system).
read more, visit following website:
http://www.proactiveinvestors.com/companies/news/17391/stem-cell-therapeutics-expands-patent-portfolio-in-us-japan-17391.html
No comments:
Post a Comment